[ad_1]
Another pharmaceutical company is underway for the vaccine. Moderna’s vaccine is nearly 95% effective. Biontech and Pfizer are already applying for emergency approval in the United States. And now AstraZeneca is also reporting good results.
AstraZeneca is not yet finished with the third test phase. But the interim results so far have been positive. According to the press release, the vaccine is effective and has not resulted in any hospitalization or serious accidents.
70% effective
The first can shows 90 percent effectiveness. The next 62 percent. This means that the AstraZeneca vaccine is around 70% effective. For comparison: Biontech and Pfizer’s vaccine is 95% effective. According to a study in the “Lancet” journal, the vaccine is particularly well tolerated by older people.
The AstraZeneca vaccine should be stored in a cool place at temperatures between two and eight degrees. It is based on the weakened version of a chimpanzee cold virus.
Prepared all over the world
Astra Zeneca is now preparing for the approval of health authorities around the world. The first tentative results of the vaccine come from the UK. AstraZeneca is developing the vaccine together with the University of Oxford. Clinical trials are also underway in the United States, Japan, Russia, South Africa, Kenya and Latin America. Up to 60,000 test people around the world will be involved. AstraZeneca has also applied for approval from Swissmedic in Switzerland.
The EU has already obtained 300 million doses of the vaccine. Switzerland will receive 5.3 million vaccine doses of this.
Source link
